Solution-focused Counseling for Menopausal Symptoms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research will be conducted in a prospective pre-test post-test measurement randomized controlled experimental design. The population of the study consists of women who have entered menopause and live in Karabük. The research sample size was calculated considering the literature information that in experimental studies each group should consist of at least 30 individuals, taking into account the power of the test with G\*Power 3.1 Program. It was calculated that at least 32 observations are needed in both the experimental and control groups to reach a power level of 90% at a significance level of 5% with an effect size of 0.75, and the sample size of the study was calculated as 64 women. The data of the study will be collected using the "Personal Information Form", "Psychological Well-being Scale", "Menopausal Symptoms Evaluation Scale" and "Menopause Attitude Evaluation Scale".

WORKFLOW

Pre-procedure:

* Women who meet the inclusion criteria for the study will be divided into experimental and control groups using simple randomization method.
* Before the procedure, women in both groups will fill out the PIF, PWBS, MSES, and MAES (1st Measurement).

During the procedure:

At this stage, Solution-Focused Counseling (SFC) will be used on women in the experimental group by the researcher. SFC sessions for patients will be held individually, once a week, with a total of 6 sessions that may have deviations of 2-3 days before or after the previous session. Each session is planned to last 60 minutes. Counseling for patients will be conducted in a comfortable environment. At this stage, women in the control group will be given information on typical menopausal symptoms.

Post-procedure:

One week after the completion of SFC sessions, the PIF, PWBS, MSES, and MAES will be filled out by the experimental and control groups (2nd Measurement).

Follow-up evaluation after 2 months:

Two months after the completion of SFC sessions, the PIF, PWBS, MSES, and MAES will be applied to the experimental and control groups (Follow-up Measurement) to determine whether the results of the applied SFC are continuing.After monitoring measurements are taken on the control group, counseling will be provided to women according to their needs (addressing issues, answering questions, informing them according to their needs).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Relationship Between Mediterranean Diet and Menopausal Symptoms in Postmenopausal Women

NCT06755255

Menopausal Complaints

COMPLETED

MHT and Liver Function in Postmenopausal Women

NCT07103603

Menopause Non Alcholic Fatty Liver Disease Hepatic Steatosis

COMPLETED NA

Diet, Cardiometabolic Risk (CM) and Menopause Symptoms

NCT05764473

Metabolic Syndrome, Protection Against Menopause

COMPLETED NA

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

NCT06975111

Menopause Menopause Hot Flashes Menopause Related Conditions +1 more

NOT_YET_RECRUITING PHASE2/PHASE3

Symptom Monitoring and Menopausal Symptoms

NCT05603234

Menopause

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this research is to examine the effectiveness of solution-focused counseling in managing menopausal symptoms and to investigate the impact of this approach on the attitudes and psychological well-being of women in the menopausal period.

H1: Solution-focused counseling affects the evaluation of menopausal symptoms in women in the menopausal period.

H2: Solution-focused counseling leads to changes in attitudes towards menopause in women in the menopausal period.

H3: Solution-focused counseling affects the level of psychological well-being of women in the menopausal period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopause Menopause Related Conditions Menopausal Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

İntervention group

Pre-Procedure: Women who meet the inclusion criteria will be divided into experimental and control groups using simple randomization method. Before the procedure, both groups will fill out the Personal Information Form (PIF), Psychological Well-being Scale (PWS), Menopausal Symptoms Assessment Scale (MSAS), and Menopause Attitude Assessment Scale(MASS) (1st Measurement).

During the Procedure: Women in the experimental group will receive Solution-Focused Counseling (SFC) by the researcher. SFC will be conducted individually once a week, in a total of 6 sessions, with each session lasting 60 minutes.

Post-Procedure: One week after the completion of SFC sessions, both groups will fill out PWS, MSAS, and MAAS again (2nd Measurement).

Follow-Up Two Months Later: Two months later, both groups will fill out PWS, MSAS, and MAAS again to evaluate whether the effects of SFC are still present (Follow-Up Measurement).

Group Type EXPERIMENTAL

Intervention

Intervention Type OTHER

1. Process: implementation of pre-tests
2. Process: Solution-focused counseling, 60 minutes once a week for a total of 6 sessions
3. Final test after 2 months

Control group

Before the procedure, women will be asked to fill out a Personal Information Form (PIF), Psychological Well-being Scale (PWS), Menopause Symptoms Assessment Scale (MSAS), and Menopause Attitude Assessment Scale (MAAS) (1st Measurement). Women in the control group will be provided with information about routine menopausal symptoms. 2 months later, the 2nd Measurement will be taken. After the follow-up measurement is taken for the control group, counseling will be provided to women according to their needs (addressing problems, answering questions, providing information as needed).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention

1. Process: implementation of pre-tests
2. Process: Solution-focused counseling, 60 minutes once a week for a total of 6 sessions
3. Final test after 2 months

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Experimental Group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Accepting to participate in the study
* Being a woman
* Having been diagnosed with menopause for at least 1 year

Exclusion Criteria

* Leaving work halfway through without filling out surveys or scales even though you stayed to work
* Having any barriers to communication
* Having received a psychiatric diagnosis

Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes